Intelligent wound care with the temporary skin substitute
SUPRATHEL® is an innovative skin substitute for the treatment of dermal wounds. The application of SUPRATHEL® leads to excellent healing results especially when used on scalds and burns, abrasions, as well as split skin graft donor sites.
SUPRATHEL® is distributed by SoCal Medical and manufactured by
Polymedics Innovations GmbH (PMI):
http://www.polymedics.de/1/home/
DermaPure® is produced using dCELL® Technology. The proprietary process maintains the essential structure of the native extracellular matrix, and preserves a high degree of the natural tissue’s biomechanical properties — meaning the DermaPure® product strongly addresses the standard put forth in the International Consensus recommendations noted above.
SUPRATHEL®
DermaPure® is a new decellularized human dermis product from Tissue Regenix, The product concept replaces human dermis with human dermis, to most closely approximate the structure and function of the native tissue it is replacing. It is NOT derived from fetal foreskin fibroblasts, bovine collagen, urinary bladders or placentas. Rather than providing a sacrificial collagen, DermaPure® provides a receptive matrix that becomes integrated into the host tissue.
DermaPure® is distributed by SoCal Medical and manufactured by
Tissue Regenix:
http://tissueregenixus.com/index.php
DermaPure®:
DermaPure®: a new treatment option for wound care.
SUPRATHEL®
Products
Just like a second skin, SUPRATHEL® covers the wound. Due to its specific properties it accelerates the healing process and reduces complications. SUPRATHEL was developed with the functionality of the human skin in mind and thus shares similar properties such as elasticity, permeability to water vapor and impermeability to bacteria. This is the basis for the excellent healing success with SUPRATHEL®